home / stock / meso / meso news


MESO News and Press, Mesoblast Limited From 05/23/24

Stock Information

Company Name: Mesoblast Limited
Stock Symbol: MESO
Market: NASDAQ
Website: mesoblast.com

Menu

MESO MESO Quote MESO Short MESO News MESO Articles MESO Message Board
Get MESO Alerts

News, Short Squeeze, Breakout and More Instantly...

MESO - Expected US Company Earnings on Thursday, May 23rd, 2024

Faraday Future Intelligent Electric Inc. (FFIE) is expected to report for Q1 2024 D-Market Electronic Services & Trading (HEPS) is expected to report for Q1 2024 Christian Dior SE ADR (CHDRY) is expected to report for Q1 2024 Check-Cap Ltd. (CHEK) is expected to report $-0.17 for ...

MESO - NIVF, BDRX and ZAPP among pre-market losers

2024-04-30 08:24:49 ET More on pre-market losers & stocks. Biodexa shares rally 126% on rapamycin licensing deal NewGenIvf signs non-binding term sheet for potential reverse merger with European Wellness Investment Holdings Seeking Alpha’s Quant Rating on ...

MESO - Appendix 4c Quarterly Activity Report for Quarter Ended March 31, 2024

NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an activity report for the third quarter ended March 31, 2024. Mesoblast Chief Executive Silviu Itescu said: ȁ...

MESO - PHG, IBRX and MESO are among premarket gainers

2024-04-29 08:36:50 ET More on premarket gainers & stock Diving Into Deciphera Pharmaceuticals Fulton Financial Corporation (FULT) Q1 2024 Earnings Call Transcript Fulton Financial Corporation 2024 Q1 - Results - Earnings Call Presentation Fulton Financia...

MESO - Mesoblast Limited: Back From The Dead

2024-04-10 13:29:22 ET Summary Mesoblast Limited has been on a major run recently as its cell therapy candidate is back on track towards potential approval. The company has some upcoming potential catalysts in the quarters ahead and is advancing its pipeline on several fronts. ...

MESO - (MESO) Investment Analysis and Advice

2024-04-07 22:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

MESO - SOL, MESO and ACOR among pre-market losers

2024-04-03 08:12:40 ET More on Pre-market losers & stocks. Emeren Group Ltd. (SOL) Q4 2023 Earnings Call Transcript Mesoblast Limited (MESO) Q2 2024 Earnings Call Transcript Mesoblast Limited 2024 Q2 - Results - Earnings Call Presentation Acorda falls 59%...

MESO - KGC, IAU, NEM, GFI, MESO showing five-day upward surge

2024-04-02 10:45:02 ET Kinross Gold Corp. (KGC) KGC is trading UP for the last 5 days, and it at trading at $6.24 with volume of 4,912,280 and a one day change of $0.08 (1.22%). Kinross Gold Corp. has a 52-week low of 4.32 and a 52-week high of $6.34. The business's 50-day moving av...

MESO - MMAT, CNTB and HGAS among mid-day movers

2024-04-01 12:57:59 ET More on Mid-day movers & stocks. Meta Materials total Q4 revenue up 55% y/y Meta Materials announces $1M civil penalty to settle SEC investigation Seeking Alpha’s Quant Rating on Connect Biopharma Historical earnings data for...

MESO - Mesoblast Ltd. (NASDAQ: MESO) Near the Top of Equities by Percentage Gain on 4/1

Mesoblast Limited (NASDAQ: MESO) is one of today's top gainers. The company's shares have moved 30.62% on the day to $6.55. Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, ...

Previous 10 Next 10